| Jessica Berman, | |
|
8270 Willow Oaks Corporate Dr, Fairfax, VA 22031-4511 | |
| (571) 423-4147 | |
| Not Available |
| Full Name | Jessica Berman |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 8270 Willow Oaks Corporate Dr, Fairfax, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033766506 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Berman, 8270 Willow Oaks Corporate Dr Ste 2127, Fairfax, VA 22031-4511 Ph: (571) 423-4147 | Jessica Berman, 8270 Willow Oaks Corporate Dr, Fairfax, VA 22031-4511 Ph: (571) 423-4147 |
News Archive
The British Society for Rheumatology has today launched a report setting out a programme of work to enhance care for people with rare rheumatic and musculoskeletal conditions.
It's very much in line with what we're seeing globally with national and even private practice initiatives – providing more patient engagement and enabling patients to see their own records.
A new study published in the March 2020 issue of the journal Neurology Clinical Practice reports that smartphone use by people who have headaches is associated with greater use of medication but less relief, compared to those who do not use smartphones when they have headaches. This does not prove that smartphone use is responsible for the increased need for drugs or the relative intractability of the headaches, but shows a linkage.
A nationwide, government-sponsored study finds that people with a common form of diabetic retinopathy can benefit from a medication first developed to combat another potentially blinding disease, age-related macular degeneration (AMD). Treating diabetic macular edema (DME) with ranibizumab (Lucentis) eye injections, plus laser treatment if needed, appears to result in better vision than laser treatment alone, according to the Diabetic Retinopathy Clinical Research (DRCR) Network study published today in Ophthalmology online, the journal of the American Academy of Ophthalmology (Academy). DME is the main cause of vision loss in people with diabetes mellitus.
Though lots of different approaches to controlling health care costs have been discussed, it's hard to know which of them will really work.
› Verified 5 days ago
Maureen Bellingham, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8270 Willow Oaks Corporate Dr Ste 2129, Fairfax, VA 22031 Phone: 571-423-4172 | |
Madison Ashlee Sunderland, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11150 Fairfax Blvd Ste 500, Fairfax, VA 22030 Phone: 201-983-9881 | |
Ana Maria Ringel, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8270 Willow Oaks Corporate Dr, Fairfax, VA 22031 Phone: 571-423-4900 | |
Carol Ann Pastoric, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8270 Willow Oaks Corporate Dr, Fairfax, VA 22031 Phone: 703-426-7039 | |
Deborah Paula Glickman, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8270 Willow Oaks Corporate Dr, Fairfax, VA 22031 Phone: 703-645-6300 | |
Ms. Hannah Sichel, MS Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 11150 Fairfax Blvd, Fairfax, VA 22030 Phone: 703-537-0373 | |
Debra L Opalesky, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8270 Willow Oaks Corporate Dr, Fairfax, VA 22031 Phone: 703-714-5907 |